Evidence map›Paper›PMID 34122725›Full record

ArticleOxidative medicine and cellular longevity2021

Molecular Basis for the Interactions of Human Thioredoxins with Their Respective Reductases.

Md Faruq Hossain, Yana Bodnar, Calvin Klein, Clara Ortegón Salas, Elias S J Arnér, Manuela Gellert, Christopher Horst Lillig

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Md Faruq HossainInstitute for Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Germany.ORCID https://orcid.org/0000-0002-8346-063X
Yana BodnarInstitute for Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Germany.ORCID https://orcid.org/0000-0002-4059-7185
Calvin KleinInstitute for Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Germany.
Clara Ortegón SalasInstitute for Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Germany.
Elias S J ArnérDepartment for Biochemistry, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-4807-6114
Manuela GellertInstitute for Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Germany.ORCID https://orcid.org/0000-0002-2545-7125
Christopher Horst LilligInstitute for Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Germany.ORCID https://orcid.org/0000-0003-2509-5117
Universitätsmedizin Greifswald · DEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mammalian cytosolic thioredoxin (Trx) system consists of Trx1 and its reductase, the NADPH-dependent seleno-enzyme TrxR1. These proteins function as electron donor for metabolic enzymes, for instance in DNA synthesis, and the redox regulation of numerous processes. In this work, we analysed the interactions between these two proteins. We proposed electrostatic complementarity as major force controlling the formation of encounter complexes between the proteins and thus the efficiency of the subsequent electron transfer reaction. If our hypothesis is valid, formation of the encounter complex should be independent of the redox reaction. In fact, we were able to confirm that also a redox inactive mutant of Trx1 lacking both active site cysteinyl residues (C32,35S) binds to TrxR1 in a similar manner and with similar kinetics as the wild-type protein. We have generated a number of mutants with alterations in electrostatic properties and characterised their interaction with TrxR1 in kinetic assays. For human Trx1 and TrxR1, complementary electrostatic surfaces within the area covered in the encounter complex appear to control the affinity of the reductase for its substrate Trx. Electrostatic compatibility was even observed in areas that do not form direct molecular interactions in the encounter complex, and our results suggest that the electrostatic complementarity in these areas influences the catalytic efficiency of the reduction. The human genome encodes ten cytosolic Trx-like or Trx domain-containing proteins. In agreement with our hypothesis, the proteins that have been characterised as TrxR1 substrates also show the highest similarity in their electrostatic properties.

Indexed as

HumansOxidoreductasesThioredoxinsOxidoreductasesThioredoxins

Identifiers

PMID34122725
PMCPMC8189816
OpenAlexW3169675314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.